Biophytis SA
Biotechnology · Paris, I0
BiotechnologySEC Form D
Biophytis SA filed a Form D with the U.S. Securities and Exchange Commission on March 23, 2026, reporting $1,584,275 raised.
Incorporated in France and based in Paris, I0, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Biophytis SA has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Stanislas VeilletExecutive Officer · Director
- Claude AllaryDirector
- Nadine CoulmDirector
- Jean MarianiExecutive Officer · Director
- Christophe CourtillatExecutive Officer
- Edouard BiethExecutive Officer
- Chiara BaccelliExecutive Officer
- Pierre DildaExecutive Officer
- Waly DiohExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised